Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4T | 2.3T | 1.3T | 1.1T |
Cost of revenue | 2.2T | 2.1T | 1.2T | 1.1T |
Gross profit | 118.1B | 151.1B | 42.0B | 76.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 10.1B | 8.9B | 14.7B | 16.4B |
Other operating expenses | 2.9B | 197.9M | 4.6B | 2.1B |
Operating income | 73.4B | 112.0B | -2.5B | 43.7B |
Non operating interest income | ||||
Income | 26.3M | -1.2B | 1.4B | 17.6M |
Expense | 15.1B | 14.5B | 12.9B | 3.9B |
Other income expense | — | — | — | — |
Pretax income | 56.1B | 98.5B | -7.1B | 34.6B |
Tax provision | 12.6B | 35.2B | -6.3B | 8.4B |
Net income | 43.6B | 63.3B | -778.9M | 26.3B |
Basic EPS | 6.1 | — | — | — |
Diluted EPS | 6.1 | — | — | — |
Basic average shares | 7.2B | — | — | — |
Diluted average shares | 7.2B | — | — | — |
EBITDA | 79.4B | 121.0B | 14.1B | 41.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 33.8M | -112.3M | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |